Current literature data for EVER1/2 polymorphisms and cervical cancer are very limited worldwide, therefore larger scale prospective studies are necessary in order to further clarify the role of these polymorphisms in cervical carcinogenesis. Here, TMC6 is linked to cervical cancer.